iSpecimen Inc. (ISPC): Nasdaq/NYSE listing notice — iSpecimen receives Nasdaq delisting notice for failing to meet minimum stockholders' equity requirement

iSpecimen Inc.

Received Nasdaq letter on June 4, 2025 regarding non-compliance with Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.
As of March 31, 2025, stockholders' equity was $1,668,513, below the $2.5M threshold; no alternative listing criteria met.
Company has 45 days to submit a compliance plan; if accepted by Nasdaq, may receive up to 180-day extension to regain compliance.
If plan not accepted or compliance not regained, Nasdaq may delist the common stock; Company can appeal to a Hearings Panel.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

iSpecimen Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

June 4, 2025, iSpecimen Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq Capital Market. As reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, the Company had stockholders’ equity of $1,668,513. Nasdaq further noted that the Company does not currently meet the alternative continued listing crite

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-051593

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.